- Home
- LEO vs SLP Comparison
LEO vs SLP Comparison
Compare LEO & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LEO | SLP |
|---|---|---|
| Founded | 1987 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | EDP Services |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 378.1M | 371.9M |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | LEO | SLP |
|---|---|---|
| Price | $5.57 | $18.48 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $17.25 |
| AVG Volume (30 Days) | ★ 162.2K | 161.6K |
| Earning Date | 01-01-0001 | 07-09-2026 |
| Dividend Yield | ★ 4.01% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.04 | ★ 0.43 |
| Revenue | N/A | ★ $59,577,000.00 |
| Revenue This Year | N/A | $3.40 |
| Revenue Next Year | N/A | $5.36 |
| P/E Ratio | $137.00 | ★ $42.95 |
| Revenue Growth | N/A | ★ 10.52 |
| 52 Week Low | $5.42 | $11.09 |
| 52 Week High | $6.55 | $21.01 |
Technical Indicators
Market Signals| Indicator | LEO | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 23.81 | 60.66 |
| Support Level | N/A | $18.22 |
| Resistance Level | $6.50 | $18.57 |
| Average True Range (ATR) | 0.06 | 0.03 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 23.40 | 77.78 |
Price Performance
Historical ComparisonAbout LEO BNY Mellon Strategic Municipals Inc.
BNY Mellon Strategic Municipals, Inc. is a diversified closed-end management investment company. The fund's investment objective is to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital. Its products include equity and fixed income mutual funds, retail money market funds, government/treasury money market funds, institutional money market funds, and others. The company and its affiliates, as well as others involved in the management, sales, investment activities, business operations, or distribution of the fund, are engaged in businesses and have interests other than those of managing the fund.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.